Management of red cell alloimmunisation in pregnancy: The non-invasive monitoring of the disease

Keyphrases

• Alloimmunization in Pregnancy 100%
• Amniocentesis 33%
• Anemia 100%
• Anti-D Immunoglobulin 33%
• Blood Products 33%
• Blood Transfusion 33%
• Cell-free Fetal DNA 33%
• Clinical Management 33%
• Copyright 33%
• Cost Implications 33%
• Disease Monitoring 100%
• Doppler Ultrasonography 33%
• Ethical Implications 33%
• Fetal DNA in Maternal Plasma 33%
• Fetal Morbidity 33%
• Fetus 66%
• Hemolytic Disease of Fetus and Newborn 66%
• Hemolytic Disease of the Newborn 66%
• Invasive Approach 66%
• Invasive Procedures 33%
• Modern Management 33%
• Neonatal Morbidity 33%
• Neonatal Mortality 33%
• Non-invasive Approach 66%
• Non-invasive Monitoring 100%
• Potential Problems 33%
• Red Cell Alloimmunization 100%
• RHD Genotyping 33%
• Severe Disease 33%
• Timely Manner 33%

Medicine and Dentistry

• Alloimmunization 100%
• Amniocentesis 25%
• Anemia 75%
• Blood Product 25%
• Blood Transfusion 25%
• Cell-Free Fetal DNA 25%
• Clinical Management 25%
• Disease 100%
• Doppler Ultrasound 25%
• Health Care Cost 25%
• Hemolytic Anemia 50%
• Immunoglobulin 25%
• Invasive Procedure 25%
• Maternal Plasma 25%
• Neonatal Infant 50%
• Newborn Morbidity 25%
• Newborn Mortality 25%
• Rhesus D Antibody 25%
• Rheumatic Heart Disease 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 75%
• Disease 100%
• Hemolytic Anemia 50%
• Immunoglobulin 25%
• Newborn Morbidity 25%
• Newborn Mortality 25%
• Noninvasive Monitoring 100%
• Rhesus D Antibody 25%
• Rheumatic Heart Disease 25%